Intrastriatal injection of opioid receptor agonists inhibits apomorphine-induced behavior in 6-hydroxydopamine-treated mice

Intrastriatal injection of opioid receptor agonists inhibits apomorphine-induced behavior in... The effects of intrastriatal (i.st.) injections of μ-, δ- and κ-selective opioid receptor agonists on the augmentation of apomorphine-induced behaviors were determined in 6-hydroxydopamine-treated mice by using multidimensional behavioral analyses. 6-Hydroxydopamine (16 μg/μl, i.st.) was unilaterally injected into the striatum 30 min after pretreatment with desipramine (25 mg/kg, s.c). Mice were tested 14 days after injection of 6-hydroxydopamine. Apomorphine (0.5 mg/kg, s.c.) produced a marked increase in linear locomotion, contralateral circling and/or rearing behavior in 6-hydroxydopamine- but not vehicle-treated mice. Although the μ-selective opioid receptor agonist ( d -Ala 2 , N -Me-Phe 4 ,Gly 5 -ol)enkephalin (DAMGO) (0.1 and 0.3 ng, i.st.) or the κ-selective opioid agonist dynorphin A-(1–13) (0.1 and 0.3 μg, i.st.) did not produce any significant effects on behavior, these peptides had an inhibitory effect on the apomorphine (0.5 mg/kg, s.c.)-induced increase in behavioral responses such as linear locomotion, contralateral circling and/or rearing behavior in 6-hydroxydopamine-treated mice. The inhibitory effects of DAMGO (0.3 ng, i.st.) and dynorphin A-(1–13) (0.3 μg, i.st.) were fully reversed by selective opioid receptor antagonists such as β-funaltrexamine (5 μg, i.c.v.) and (−)-(1 R ,5 R ,9 R )-5,9-diethyl-2-(3-furyl-methyl)-2′-hydroxy-6,7-benzomorphan (Mr2266) (10 mg/kg, s.c.), respectively. In contrast, the δ-selective opioid receptor agonist ( d -Pen 2 , l -Pen 5 )enkephalin (DPLPE) (0.03, 0.1 or 0.3 μg, i.st.) had no marked effects on the apomorphine (0.5 mg/kg, s.c.)-induced behavior in 6-hydroxydopamine-treated mice. These results suggest that the stimulation of μ- and κ- but not δ-opioid receptors plays an inhibitory role in the behavioral augmentation induced by the activation of postsynaptic dopamine receptors in the striatum sensitized with 6-hydroxydopamine. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Pharmacology Elsevier

Intrastriatal injection of opioid receptor agonists inhibits apomorphine-induced behavior in 6-hydroxydopamine-treated mice

Loading next page...
 
/lp/elsevier/intrastriatal-injection-of-opioid-receptor-agonists-inhibits-EcIRUMNhX6
Publisher
Elsevier
Copyright
Copyright © 1995 Elsevier Ltd
ISSN
0014-2999
DOI
10.1016/0014-2999(95)00601-X
Publisher site
See Article on Publisher Site

Abstract

The effects of intrastriatal (i.st.) injections of μ-, δ- and κ-selective opioid receptor agonists on the augmentation of apomorphine-induced behaviors were determined in 6-hydroxydopamine-treated mice by using multidimensional behavioral analyses. 6-Hydroxydopamine (16 μg/μl, i.st.) was unilaterally injected into the striatum 30 min after pretreatment with desipramine (25 mg/kg, s.c). Mice were tested 14 days after injection of 6-hydroxydopamine. Apomorphine (0.5 mg/kg, s.c.) produced a marked increase in linear locomotion, contralateral circling and/or rearing behavior in 6-hydroxydopamine- but not vehicle-treated mice. Although the μ-selective opioid receptor agonist ( d -Ala 2 , N -Me-Phe 4 ,Gly 5 -ol)enkephalin (DAMGO) (0.1 and 0.3 ng, i.st.) or the κ-selective opioid agonist dynorphin A-(1–13) (0.1 and 0.3 μg, i.st.) did not produce any significant effects on behavior, these peptides had an inhibitory effect on the apomorphine (0.5 mg/kg, s.c.)-induced increase in behavioral responses such as linear locomotion, contralateral circling and/or rearing behavior in 6-hydroxydopamine-treated mice. The inhibitory effects of DAMGO (0.3 ng, i.st.) and dynorphin A-(1–13) (0.3 μg, i.st.) were fully reversed by selective opioid receptor antagonists such as β-funaltrexamine (5 μg, i.c.v.) and (−)-(1 R ,5 R ,9 R )-5,9-diethyl-2-(3-furyl-methyl)-2′-hydroxy-6,7-benzomorphan (Mr2266) (10 mg/kg, s.c.), respectively. In contrast, the δ-selective opioid receptor agonist ( d -Pen 2 , l -Pen 5 )enkephalin (DPLPE) (0.03, 0.1 or 0.3 μg, i.st.) had no marked effects on the apomorphine (0.5 mg/kg, s.c.)-induced behavior in 6-hydroxydopamine-treated mice. These results suggest that the stimulation of μ- and κ- but not δ-opioid receptors plays an inhibitory role in the behavioral augmentation induced by the activation of postsynaptic dopamine receptors in the striatum sensitized with 6-hydroxydopamine.

Journal

European Journal of PharmacologyElsevier

Published: Dec 29, 1995

References

  • The effects of opioid peptides on dopamine release in the nucleus accumbens: An in vivo microdialysis study
    Spanagel, R.; Herz, A.; Shippenberg, T.S.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off